CFX - CFX STOCK NEWS

DJO, a leading global provider of medical technologies, announced its acquisition of Trilliant Surgical, enhancing its presence in the $1 billion US foot and ankle market. This acquisition brings innovative product technologies, including the Arsenal Foot Plating System, which improves surgical efficiency. CEO Brady Shirley emphasized this move aligns with DJO's strategy to expand its Reconstructive segment. The growing elderly population and increased prevalence of diabetes contribute to the foot and ankle market's potential, positioning DJO for future growth.

DJO, a global leader in medical technologies, has acquired LiteCure®, a leading provider of therapeutic laser technology for human and animal health. This acquisition aims to enhance DJO's market position in recovery sciences, leveraging LiteCure's advanced laser therapies to improve patient outcomes. The integration is expected to foster innovation and expand DJO's offerings in physical therapy and animal health, particularly with LiteCure's products marketed under LightForce® and Companion® brands. CEO Brady Shirley emphasized the synergy between the two companies as a key driver for this acquisition.

DJO, LLC has completed the acquisition of total ankle and finger arthroplasty product lines from Stryker, enhancing its position in the medical technology sector. This acquisition includes the STAR® total ankle arthroplasty system known for its superior clinical outcomes, and the comprehensive finger joint arthroplasty products, including Silicone and TACTYS® implants. Ankle replacements have seen significant growth in the U.S., highlighting a shift toward ankle implants over fusion surgery. The acquisition aims to address a larger patient base and support DJO's mission of promoting active lifestyles.

Colfax Corporation (NYSE: CFX) reported third-quarter 2020 net income of $16.0 million, or $0.12 per share, up from $0.02 in Q3 2019. Adjusted EPS was $0.41, down from $0.50 the previous year. Net sales reached $806 million, reflecting a 5% year-over-year decline due to COVID-19 impacts, though sequentially sales increased by 30%. Medical Technology segment experienced 2% growth, while Fabrication Technology segment sales fell 9%. The company announced plans to acquire extremity product lines with expected sales of $20 million. Adjusted earnings for Q4 are projected between $0.45 and $0.50.

Colfax Corporation (NYSE: CFX) announced that it will release its third-quarter financial results on October 29, 2020. A conference call to discuss these results will take place at 8:00 a.m. Eastern, accessible via phone and webcast. Prior to the call, the financial press release and any supplemental information will be available on Colfax’s website. This leading diversified technology company provides orthopedic and fabrication technology products globally under the DJO and ESAB brands, leveraging the Colfax Business System to enhance value for stakeholders.

DJO, a subsidiary of Colfax Corporation (NYSE: CFX), launched the AltiVate® Anatomic CS EDGE™ Shoulder System, a less invasive solution aimed at improving bone conservation in shoulder surgeries. The U.S. sees about 67,000 anatomic total shoulder arthroplasties annually, projected to grow by 8.6% in two years. The new system features a canal-sparing design with a 3-fin humeral stem and proprietary P^2™ titanium coating, enhancing stability and bone in-growth during surgery. This innovation targets the growing active patient population.

Colfax Corporation (NYSE: CFX) reported Q2 2020 financial results, showing a net loss of $3.6 million or $(0.03) per share, a decline from net income in the prior year. However, adjusted EPS was $0.09, down from $0.54 last year. Sales were $620 million, reflecting a 32% decrease year-over-year due to COVID-19, with organic sales down 28%. Notably, the company achieved operating cash flow of $37 million and free cash flow of $18 million. Despite challenges, monthly sales showed sequential improvement. Colfax launched over 35 new products, aiming for long-term growth despite current market conditions.

Colfax Corporation (NYSE: CFX) announced it will release its financial results for Q2 2020 on August 6, 2020. A conference call is scheduled for 8:00 a.m. Eastern time, open to the public via phone and webcast. Financial results and supplemental information will be posted on Colfax’s website before the call. The company, known for its orthopedic and fabrication technology products under the DJO and ESAB brands, emphasizes its strong brand recognition and the use of its Colfax Business System to enhance shareholder value.